PRPH
protein-codingperipherin, the group of Intermediate filaments Type III
Gene summary
This gene encodes a cytoskeletal protein found in neurons of the peripheral nervous system. The encoded protein is a type III intermediate filament protein with homology to other cytoskeletal proteins such as desmin, and is a different protein that the peripherin found in photoreceptors. Mutations in this gene have been associated with susceptibility to amyotrophic lateral sclerosis. [provided by RefSeq, Jul 2008]
- NEF4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007103
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0007103
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0004976
Submitter: ClinGen
*PRPH* was first reported in relation to amyotrophic lateral sclerosis 7(ALS) in 2004 (Leung et al., PMID: 15446584). This individual had a homozygous missense variant, Asp141Tyr, which has since been found to occur at a frequency of 0.3% (based on the total gnomADv2.1.1 non-neuro population) and is not considered plausibly causative of ALS for this curation. Since 2004 rare heterozygous variants have been identified in additional ALS patients and an autosomal dominant mechanism has been considered here. *PRPH* encodes peripherin, a neuronal-specific intermediate filament protein expressed predominantly in the peripheral nervous system. Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 4 plausibly causative, rare variants have been reported in relation to ALS (including frameshift and missense variants). Variants in this gene have been reported in at least 4 probands in 3 publications (PMIDs: 15322088, 25299611, 26742954). Experimentally, this gene-disease relationship is supported by its expression in the nerous system (PMID: 3339087) and the fact that it is a major component found in inclusions of patients with ALS (PMID: 14675609). Additionally, an mouse model with overexpression of *PRPH* (PMID: 15132161) showed massive and selective degeneration of motor axons during aging. In summary, there is limited evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged.
Inheritance Pattern: AD
Disease ID:MONDO:0007103
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRPH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006262.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 5 | 7 | |||
| missense | 83 | 3 | 3 | 89 | ||
| nonsense | 2 | 3 | 5 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 3 | |||
| Total | 0 | 4 | 90 | 9 | 3 | 106 |
Highest pathogenic variant AF is 0.000011152168
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006253.2 | 9 | MANE Select | |
| Ensembl | ENSP00000257860.4 | 9 | MANE Select | |
| Ensembl | ENSP00000408897.4 | 6 | Standard | |
| Ensembl | ENSP00000437182.2 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human)
- Amyotrophic lateral sclerosis (ALS)
Molecular Function
- structural molecule activity
- protein binding
Cellular Component
- intermediate filament
- membrane
- type III intermediate filament
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000257860
- Coding exons
- 9
- Length
- 5431
- Individuals with no LoFs
- 124482
- Homozygous LoFs
- 6
- Heterozygous LoFs
- 1260
- Defined
- 125748
- p
- 0.00505
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.556 | 245 | 271 | 0.905 | 0.0000141 | 2987 |
| Missense (PolyPhen) | 98 | 102.02 | 0.96057 | 1111 | ||
| Synonymous | 0.163 | 121 | 123 | 0.981 | 0.00000620 | 965 |
| Loss of Function | 0.171 | 21 | 21.9 | 0.961 | 0.00000100 | 241 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00075 | 0.00074 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00099 | 0.00098 | rare |
| Finnish | 0.022 | 0.022 | notable |
| European (Non-Finnish) | 0.0063 | 0.0063 | notable |
| South Asian | 0.00077 | 0.00075 | rare |
| Other | 0.0026 | 0.0026 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Class-III neuronal intermediate filament protein.;
Recessive Scores
- pRec
- 0.412
Intolerance Scores
- LoFtool
- 0.394
- RVIS EVS
- 0.02
- RVIS percentile EVS
- 55.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.769
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |